Rankings
▼
Calendar
BCRX FY 2006 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
FY 2006 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$6M
Gross Profit
$6M
100.0% margin
Operating Income
-$47M
-756.3% margin
Net Income
-$44M
-702.2% margin
EPS (Diluted)
$-1.50
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$17M
Stock-Based Comp.
$3.3B
Balance Sheet
Total Assets
$68M
Total Liabilities
$47M
Stockholders' Equity
$21M
Cash & Equivalents
$4M
← FY 2007
All Quarters
